Pharmaceutical products for the treatment of neurological diseases or disorders; pharmaceutical products for the treatment of autoimmune diseases or disorders; pharmaceutical products for the treatment of multiple sclerosis; pharmaceutical products for the treatment of relapsing forms of MS; pharmaceutical products for the treatment of clinically isolated syndrome; pharmaceutical products for the treatment of relapsing-remitting disease; pharmaceutical products for the treatment of active se...